T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.27% |
| 5 | Technology | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NRF
1576
DELISTED
NorthStar Realty Finance Corp.
NRF
| $1.86M | ﹤0.01% |
54,649
+3,489
| +7% | +$110K |
|
|
PTP
1577
DELISTED
PLATINUM UNDERWRITERS HLDGS LTD
PTP
| $1.85M | ﹤0.01% |
28,600
+8,400
| +42% | +$528K |
|
|
BTUI
1578
DELISTED
BTU INTERNATIONAL INC
BTUI
| $1.84M | ﹤0.01% |
564,260
-53,930
| -9% | -$159K |
|
|
PRE
1579
DELISTED
PARTNERRE LTD
PRE
| $1.83M | ﹤0.01% |
16,800
+1,700
| +11% | +$179K |
|
|
EGN
1580
DELISTED
Energen
EGN
| $1.82M | ﹤0.01% |
20,521
-2,478
| -11% | -$208K |
|
1581
Brown & Brown
BRO
$23.8B
| $1.82M | ﹤0.01% |
118,612
-7,260,520
| -98% | -$109M |
|
1582
Broadridge
BR
$19.5B
| $1.8M | ﹤0.01% |
43,325
+1,200
| +3% | +$47K |
|
1583
iShares MSCI EAFE ETF
EFA
$80.3B
| $1.8M | ﹤0.01% |
26,350
+350
| +1% | +$24K |
|
|
FRC
1584
DELISTED
First Republic Bank
FRC
| $1.8M | ﹤0.01% |
32,743
+843
| +3% | +$44.3K |
|
1585
RenaissanceRe
RNR
$13.4B
| $1.8M | ﹤0.01% |
16,800
+300
| +2% | +$30.7K |
|
|
WR
1586
DELISTED
Westar Energy Inc
WR
| $1.8M | ﹤0.01% |
47,050
+8,000
| +20% | +$287K |
|
1587
Essential Utilities
WTRG
$11.4B
| $1.79M | ﹤0.01% |
68,228
+6,100
| +10% | +$153K |
|
|
STNR
1588
DELISTED
STEINER LEISURE LTD
STNR
| $1.78M | ﹤0.01% |
41,200
| – | – |
|
1589
Synopsys
SNPS
$80.8B
| $1.78M | ﹤0.01% |
45,750
+4,502
| +11% | +$172K |
|
|
TWO
1590
Two Harbors Investment
TWO
$1.26B
| $1.77M | ﹤0.01% |
21,075
+5,837
| +38% | +$485K |
|
1591
Oshkosh
OSK
$9.46B
| $1.76M | ﹤0.01% |
31,773
-440
| -1% | -$24.3K |
|
1592
ITT
ITT
$19.6B
| $1.75M | ﹤0.01% |
36,400
+4,000
| +12% | +$178K |
|
|
S
1593
DELISTED
Sprint Corporation
S
| $1.75M | ﹤0.01% |
205,285
-44,396
| -18% | -$390K |
|
1594
NCR Voyix
VYX
$1.13B
| $1.75M | ﹤0.01% |
81,062
+628
| +0.8% | +$12.7K |
|
1595
SPX Corp
SPXC
$10.9B
| $1.73M | ﹤0.01% |
63,572
+3,971
| +7% | +$103K |
|
1596
Reinsurance Group of America
RGA
$16.3B
| $1.73M | ﹤0.01% |
21,920
| – | – |
|
1597
Arrow Electronics
ARW
$10.8B
| $1.71M | ﹤0.01% |
28,375
+500
| +2% | +$29.1K |
|
1598
Suncor Energy
SU
$77.1B
| $1.7M | ﹤0.01% |
39,800
+31,200
| +363% | +$1.22M |
|
1599
CoreCivic
CXW
$3.21B
| $1.7M | ﹤0.01% |
51,704
+14,700
| +40% | +$480K |
|
1600
CNO Financial Group
CNO
$5.11B
| $1.67M | ﹤0.01% |
94,068
+5,549
| +6% | +$94.6K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.